FUEL METABOLISM IN GROWTH HORMONE-DEFICIENT ADULTS

被引:17
作者
JORGENSEN, JOL
MOLLER, N
WOLTHERS, T
MOLLER, J
GROFTE, T
VAHL, N
FISKER, S
ORSKOV, H
CHRISTIANSEN, JS
机构
[1] AARHUS UNIV HOSP,DEPT INTERNAL MED ENDOCRINOL & DIABET,DK-8000 AARHUS,DENMARK
[2] AARHUS UNIV,INST EXPTL CLIN RES,DK-8000 AARHUS,DENMARK
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1995年 / 44卷 / 10期
关键词
D O I
10.1016/0026-0495(95)90229-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Apart from being a stimulator of longitudinal growth, growth hormone (GH) regulates fuel metabolism in children and adults. A halfmark is mobilization of lipids, which involves an inhibition of lipoprotein lipase activity in adipose tissue and activation of the hormone sensitive lipase. Suppression of basal glucose oxidation and resistance to insulin are other important effects. This may cause concern during GH substitution in GH-deficient adults, some of whom may present with insulin resistance due to concomitant abdominal obesity. However, there are data to suggest that the GH-induced reduction in fat mass and increase in lean body mass may offset the insulin antagonistic actions of the hormone. The nitrogen-retaining effects of GH seem to involve a direct stimulation of protein synthesis in addition to secondary effects such as generation of insulin-like growth factor-I (IGF-I), hyperinsulinemia, and promotion of lipolysis. Thus, during periods of substrate affluence, GH acts in concert with insulin and IGF-I to promote protein anabolism. Postabsorptively, GH is primarily lipolytic and thereby indirectly protein-sparing. This effect becomes further accentuated with more prolonged fasting. In that sense, GH is unique by its preservation of protein during both feast and famine. These fuel metabolic effects add merit to the principle of GH substitution in hypopituitary adults. Copyright (C) 1995 by W.B. Saunders Company.
引用
收藏
页码:103 / 107
页数:5
相关论文
共 33 条
[1]   EFFECT OF LONG-TERM RHGH ADMINISTRATION IN GH-DEFICIENT ADULTS ON FAT-CELL EPINEPHRINE RESPONSE [J].
BEAUVILLE, M ;
HARANT, I ;
CRAMPES, F ;
RIVIERE, D ;
TAUBER, MT ;
TAUBER, JP ;
GARRIGUES, M .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (03) :E467-E472
[2]   WHOLE-BODY LEUCINE TURNOVER IN ADULTS ON CONVENTIONAL TREATMENT FOR HYPOPITUITARISM [J].
BESHYAH, SA ;
SHARP, PS ;
GELDING, SV ;
HALLIDAY, D ;
JOHNSTON, DG .
ACTA ENDOCRINOLOGICA, 1993, 129 (02) :158-164
[3]  
BOUGNERES PF, 1985, J CLIN ENDOCR METAB, V61, P152
[4]   GROWTH-HORMONE, CORTISOL, OR BOTH ARE INVOLVED IN DEFENSE AGAINST, BUT ARE NOT CRITICAL TO RECOVERY FROM, HYPOGLYCEMIA [J].
BOYLE, PJ ;
CRYER, PE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (03) :E395-E402
[5]   AN EVALUATION OF SEVENTY-FIVE PATIENTS WITH HYPOPITUITARISM BEGINNING IN CHILDHOOD [J].
BRASEL, JA ;
WRIGHT, JC ;
WILKINS, L ;
BLIZZARD, RM .
AMERICAN JOURNAL OF MEDICINE, 1965, 38 (04) :484-+
[6]   EFFECT OF GROWTH-HORMONE ON CARBOHYDRATE AND LIPID-METABOLISM [J].
DAVIDSON, MB .
ENDOCRINE REVIEWS, 1987, 8 (02) :115-131
[7]   EFFECTS OF TREATMENT WITH RECOMBINANT HUMAN GROWTH-HORMONE ON INSULIN SENSITIVITY AND GLUCOSE-METABOLISM IN ADULTS WITH GROWTH-HORMONE DEFICIENCY [J].
FOWELIN, J ;
ATTVALL, S ;
LAGER, I ;
BENGTSSON, BA .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (11) :1443-1447
[8]   HUMAN PITUITARY GROWTH-HORMONE (HGH) THERAPY IN GROWTH-HORMONE DEFICIENCY [J].
FRASIER, SD .
ENDOCRINE REVIEWS, 1983, 4 (02) :155-170
[9]  
FRYBURG DA, 1992, AM J PHYSIOL, V260, pE499
[10]   EFFECTS OF HUMAN GROWTH HORMONE ON LEVELS OF BLOOD AND URINARY CARBOHYDRATE AND FAT METABOLITES IN MAN [J].
HENNEMAN, DH ;
HENNEMAN, PH .
JOURNAL OF CLINICAL INVESTIGATION, 1960, 39 (08) :1239-1245